Clinical Trials Search Results

  • Resize font
  • Print
  • Email
  • Facebook
  • Twitter
  • Google+
  • Pinterest

Initial search results include only NCI-sponsored clinical trials. To search all trials, click the "REFINE SEARCH" button, scroll down to the Trial ID/Sponsor section and select the "All" check box in the Sponsor of Trial section.

View Content for:
Display:
?
Drug:  ascorbic acid
Find trials that include:  Any drugs shown
Trial Status:  Closed
Results 1-25 of 32 for your search:
Start Over
Phase III Chemotherapy with IPP, IPP/ADR and CIA (IPP/ADR/CCNU) for Extensive non-Oat Cell Lung Carcinoma (Summary last modified 06/97)
Phase: Phase III
Type: Treatment
Status: Completed
Age: no age specified
Sponsor: NCI
Protocol IDs: SWOG-7701
Phase III Vitamin C vs Placebo in Patients with Advanced Colorectal Cancer Who Have Had No Prior Immunosuppressive Therapy
Phase: Phase III
Type: Treatment
Status: Closed
Age: no age specified
Sponsor:
Protocol IDs: MAYO-790602
Study of the Effect of Nutritional Intervention on Esophageal Cancer in Linxian, People's Republic of China (Summary Last Modified 10/88)
Phase: Phase III
Type: Prevention
Status: Completed
Age: 40 to 69
Sponsor:
Protocol IDs: DCPC-CPSB-11204
Phase I/II Study of High-Dose Ascorbic Acid Potentiation of Alkylating Agents in Children with Advanced Cancer in Relapse
Phase: Phase II, Phase I
Type: Treatment
Status: Closed
Age: under 18
Sponsor:
Protocol IDs: MDA-P-7901n
Velcade, Trisenox, Vitamin C and Melphalan for Myeloma Patients
Phase: Phase II, Phase I
Type: Treatment
Status: Completed
Age: 75 and under
Sponsor: Other
Protocol IDs: 2005-0893, NCT00469209
Trial of Chemotherapy Plus Intravenous Vitamin C in Patients With Advanced Cancer for Whom Chemotherapy Alone is Only Marginally Effective
Phase: Phase II, Phase I
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: Other
Protocol IDs: VITC-003, NCT01050621
Phase II Ifosfamide Chemotherapy for Resistant Disseminated Malignant Melanoma
Phase: Phase II
Type: Treatment
Status: Closed
Age: no age specified
Sponsor: NCI
Protocol IDs: SWOG-7813
Phase II Induction and Maintenance Combination Chemotherapy with IHOP (ADR/IPP/PRED/VCR) for Acute Lymphocytic Leukemia in Relapse
Phase: Phase II
Type: Treatment
Status: Closed
Age: under 75
Sponsor: NCI
Protocol IDs: SWOG-7842
Phase II Induction with High-Dose Prednisone plus VCR/MTX Followed by Aggressive Consolidation Chemotherapy for Refractory non-Hodgkin's Lymphoma
Phase: Phase II
Type: Treatment
Status: Closed
Age: no age specified
Sponsor:
Protocol IDs: NCI-D81-035-695, OSU-IOU-8107
Phase II Trials of 13 Additional Chemotherapeutic Agents, Alone or Combined for non-Small Cell Lung Cancer
Phase: Phase II
Type: Treatment
Status: Completed
Age: no age specified
Sponsor: NCI
Protocol IDs: EST-2575-II
Phase II Study of Arsenic Trioxide, Ascorbic Acid, and Dexamethasone in Patients With Relapsed or Refractory Stage II or III Multiple Myeloma
Phase: Phase II
Type: Treatment
Status: Closed
Age: 18 and over
Sponsor: Other
Protocol IDs: MWCRG-CTI-T12017, MWCRG-03-82, MWCRG-WIRB-20040041
Arsenic Trioxide, Ascorbic Acid, Dexamethasone, and Thalidomide in Myelofibrosis/Myeloproliferative Disorder
Phase: Phase II
Type: Treatment
Status: Completed
Age: Over 18
Sponsor: NCI, Other
Protocol IDs: CASE4Y04, P30CA043703, CCF-7671, CASE-CCF-7671, NCT00274820
Safety of Antioxidants During GYN Cancer Care
Phase: Phase II
Type: Treatment
Status: Completed
Age: No age specified
Sponsor: Other
Protocol IDs: 10006, NCT00284427
Bortezomib, Ascorbic Acid, and Melphalan in Treating Patients With Newly Diagnosed Multiple Myeloma
Phase: Phase II
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: Other
Protocol IDs: CDR0000479708, ONCOTHER-20052183, ONCOTHER-BAM2005, MILLENNIUM-ONCOTHER-20052183, NCT00317811
L-Ascorbic Acid Depletion to Treat Acute Myeloid Leukemia and Myelodysplastic Syndromes
Phase: Phase II
Type: Treatment
Status: Temporarily closed
Age: No age specified
Sponsor: Other
Protocol IDs: SMCIRB-98-04-02, NCT00329498
Cephalon Decitabine, Arsenic Trioxide and Ascorbic Acid for Myelodysplastic Syndrome
Phase: Phase II
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: Other
Protocol IDs: Pro00011792, 7667A, NCT00621023
Vitamin C as an Anti-cancer Drug
Phase: Phase II
Type: Biomarker/Laboratory analysis, Treatment
Status: Completed
Age: 18 and over
Sponsor: Other
Protocol IDs: 2008-008692-33, NCT01080352
Study of High Dose Intravenous (IV) Ascorbic Acid in Measurable Solid Tumor Disease
Phase: Phase II
Type: Supportive care, Treatment
Status: Temporarily closed
Age: 18 and over
Sponsor: Other
Protocol IDs: L500HD, NCT01125449
Phase I Randomized Study of Selenium With or Without Vitamin E for the Prevention of Lung Cancer in Smokers (Summary Last Modified 11/2000)
Phase: Phase I
Type: Prevention
Status: Closed
Age: 18 to 70
Sponsor: NCI
Protocol IDs: KUMC-7159-97, NCI-P00-0152
Arsenic Trioxide and Ascorbic Acid Combined With Bortezomib, Thalidomide, and Dexamethasone in Treating Patients With Relapsed or Refractory Multiple Myeloma or Plasma Cell Leukemia
Phase: Phase I
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: NCI, Other
Protocol IDs: CDR0000445464, P30CA022453, WSU-D-2869, WSU-HIC-01705M1F, NCT00258245
Study of High-Dose Intravenous (IV) Vitamin C Treatment in Patients With Solid Tumors
Phase: Phase I
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: Other
Protocol IDs: CTCA 06-04, Ascorbic Acid Injection, NCT00441207
Decitabine, Arsenic Trioxide and Ascorbic Acid for Myelodysplastic Syndromes and Acute Myeloid Leukemia
Phase: Phase I
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: Other
Protocol IDs: 07-0916 / 201011797, NCT00671697
Intravenous Vitamin C in Combination With Standard Chemotherapy for Pancreatic Cancer
Phase: Phase I
Type: Treatment
Status: Completed
Age: 18 to 75
Sponsor: Other
Protocol IDs: IND77486, NCT00954525
Start Over